Company intelligence / Profile preview

MACH32

Edmonton, Alberta, Canadamach32.net ↗
Ownership
Private
Development stage
Preclinical
01

Overview

MACH32 has developed IMSAFE, a novel high-volume intramuscular autoinjector for rapid delivery of tranexamic acid to treat life-threatening bleeding. Functional prototypes have been tested with military partners. The company has received BARDA funding to advance development and aims for regulatory submission with the FDA and Health Canada. No clinical trial results are yet available; preclinical testing and regulatory preparations are ongoing.

Therapeutic areas
Women's HealthHematology
Modalities
Device (autoinjector)Small molecule (tranexamic acid)Drug-device combination product
Industry
Therapeutic Medical Devices
02

Drug pipeline

1 asset

tranexamic acid

Pre-clinical
Indications
Traumatic bleeding, Hemorrhage
03

Partnerships

Canadian military research collaborationUS military research collaborationBiomedical Advanced Research and Development Authority (BARDA) contract

Beyond the preview

Go deeper on MACH32.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MACH32.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call